Close Close

Life Health > Health Insurance

World’s drug bill to rise to $1.4 trillion in 2020, report says

Your article was successfully shared with the contacts you provided.

(Bloomberg) — The world’s annual pharmaceutical bill will grow by about a third to $1.4 trillion in 2020 as brand-name drugs for cancers and rare diseases come to market, according to researchers at the IMS Institute for Healthcare Informatics.

Among the report’s top findings:

  • So-called specialty therapies will dominate spending, with oncology treatments totaling $110 billion, followed by autoimmune drugs. Treatments for viral hepatitis, including Gilead Science Inc.’s hepatitis C drugs Sovaldi and Harvoni along with AbbVie Inc.’s Viekira Pak, will make up $48 billion.

  • The United States will spend the most on drugs, with 41 percent of the global bill. China will spend $150 billion to $180 billion in 2020, representing a 6 percent to 9 percent compound annual growth rate. The global growth rate is 4 percent to 7 percent.

  • IMS estimates 225 new treatments will be introduced in the next five years. Of these, drugs for rare diseases and cancers will dominate.

See also: Goldman Sachs: Health care costs are about to start pushing core inflation higher


© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.